Covered on Most Formularies
QVAR® is covered for 98% of insured lives, and has preferred coverage for 92%. QVAR® also has preferred status on all five major national healthcare plans. Your covered patients may be able to pay less for QVAR® while still receiving all the benefits.1
At present, there are no generic alternatives for any product in the ICS class.
Patients who wish to know their out-of-pocket costs should be advised to call their insurance companies. The following suggestions may be useful to them:
- The phone number for your insurance company is usually found on the back of your insurance card.
- Patients may wish to use the following series of questions:
- Does my health plan include prescription drug coverage?
- Is QVAR® covered by my health plan?
- What will my out-of-pocket costs for QVAR® be?
Indication
QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age or older. QVAR® is also indicated for asthma patients who require systemic corticosteroid administration, where adding QVAR® may reduce or eliminate the need for systemic corticosteroids.
Important Safety Information
QVAR® is not a bronchodilator and is not indicated for relief of acute bronchospasm.
CAUTION: Adrenal insufficiency may occur when transferring patients from systemic steroids (see WARNINGS, Prescribing Information).
A reduction in growth velocity in growing children and teenagers may occur as a result of inadequate control of chronic diseases such as asthma or from use of corticosteroids for treatment
Common side effects associated with the use of QVAR® and placebo in clinical trials include, but are not limited to, headache (12% and 9% respectively) and pharyngitis (8% and 4% respectively).